The initial rollout targets the Bunia and Mongbwalu zones in Ituri province, which authorities identified as among the areas hardest-hit by the virus. Health officials are administering the Ervebo vaccine, a product that has been effective in past Ebola outbreaks caused by a different, more common strain of the virus. However, the current outbreak is driven by the Bundibugyo virus, for which there is currently no licensed vaccine or specific treatment. Clinical trials are ongoing to develop a licensed intervention for this specific variant.
The vaccination campaign is expected to cover approximately 20,000 front-line workers across Ituri and North Kivu provinces over a period of six to nine months. Maj. Gen. Gaby Kasongo Mulumba, the military governor of Ituri, emphasized the necessity of the measure, stating, “Our collective duty is to protect life. Launching this vaccination drive for front-line staff in Ituri is not an arbitrary choice, as these workers are particularly exposed and deeply involved in the response.”
The outbreak has resulted in significant mortality and morbidity across the region. As of Saturday, government figures recorded 7,541 confirmed cases, including 3,639 deaths. Additionally, 1,823 people have recovered from the illness. The concentration of cases in Ituri province has made this the deadliest of the 17 Ebola outbreaks previously recorded in the country. The virus has also spread to a seventh province, indicating a widening geographical footprint for the crisis.
While the use of Ervebo provides immediate protective measures for those at the forefront of the response, its efficacy against the Bundibugyo strain is not the same as its proven track record with other variants. The distinction is critical for public health planning, as the ongoing trials for a Bundibugyo-specific vaccine remain the primary path toward a targeted medical solution. Until those trials conclude, the administration of existing vaccines to high-risk groups represents the primary strategy to mitigate further transmission among healthcare providers.
